FDA Inspection
Lilly del Caribe, IncLilly del Caribe, Inc – FDA Inspection, Feb 16, 2024
Record Details
This FDA Inspection record concerns Lilly del Caribe, Inc, with an inspection on February 16, 2024, issued by the San Juan District Office, covering human drugs.
View Company Profile
ID · aedecde0-2590-423e-86f0-17deff2cbaac
Inspection Facts
- Inspection number
- 1232628
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lilly del Caribe, Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2026 | VAI | San Juan District Office | Drug Quality Assurance |
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly del Caribe, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.